Research Snapshot
What is CJC-1295 / Ipamorelin?
CJC-1295 was designed as a longer-acting GHRH analog, while ipamorelin was developed as a selective growth-hormone secretagogue. They are frequently discussed together because they engage different upstream receptors.
The label “CJC-1295” can refer to materially different preparations. Whether a product includes a drug-affinity complex changes expected duration.
Mechanism of Action
CJC-1295 stimulates the GHRH receptor, while ipamorelin activates the growth-hormone secretagogue receptor. The pairing is intended to study complementary signaling rather than duplicate the same mechanism.
Overwatch Wellness pathway visual: a simplified educational model showing how a compound can influence a biological pathway, downstream signal, and measured research outcome.
Research Focus
How Overwatch Wellness interprets the evidence
The evidence rating considers human relevance, study design, replication, and whether findings apply to the specific route or formulation being discussed. Mechanistic plausibility is useful, but it does not replace controlled human outcomes.
Limited human and preclinical evidence. Research conclusions may change as larger or longer studies are published.
Research Timing: Morning or Evening?
Often discussed in evening or fasting-state research because endogenous growth-hormone pulses commonly rise during early sleep and food intake can influence metabolic signaling. This is a research rationale, not a universal rule.
Often chosen when research centers on daytime metabolism, activity, or routine consistency.
Often discussed when research relates to sleep physiology, fasting windows, or overnight signaling.
Consistency, validated study design, and clear documentation matter more than internet timing rules.
Frequently Researched With
These relationships are included because the compounds are commonly discussed within adjacent pathways or research goals. They are not personal-use recommendations.
Compare CJC-1295 / Ipamorelin
Overwatch Wellness comparison pages separate mechanism, evidence strength, research focus, limitations, and regulatory context so similar compounds are not treated as interchangeable.
Open Compare CompoundsCertificate of Analysis
Overwatch Wellness standardizes the display of every certificate. Fields not clearly shown in the original document are labeled “See original certificate” rather than inferred.
View Full CertificateCJC-1295 without DAC 5 mg / Ipamorelin 5 mg — certificate 2602120212, lot 001. Reported purity: 99.647%. Net content: Ipamorelin 5.04 mg and CJC-1295 5.22 mg. Reported February 14, 2026.
View Additional CertificateFrequently Asked Questions
What is CJC-1295 / Ipamorelin?
GHRH analog plus ghrelin-receptor agonist.
Why is it being researched?
Researchers are interested in growth-hormone pulsatility, igf-1 signaling, sleep research, body composition.
Is there a preferred morning or evening time?
Often discussed in evening or fasting-state research because endogenous growth-hormone pulses commonly rise during early sleep and food intake can influence metabolic signaling. This is a research rationale, not a universal rule.
What does the evidence rating mean?
Limited human and preclinical evidence. Click the evidence badge near the top of this page for the full Overwatch Wellness scale.
What is the half-life?
Depends on the CJC-1295 form; DAC and non-DAC versions should never be treated as interchangeable.
What is it commonly researched with?
Overwatch Wellness connects this page to Tesamorelin, NAD+, MOTS-c because the compounds are discussed in related or complementary research pathways.
Does “commonly researched with” mean a recommendation?
No. It describes recurring research discussion and complementary mechanisms, not a personal-use recommendation.
How should a COA be interpreted?
Review identity, purity, lot number, test method, laboratory, and whether the document is supplier-issued or independently generated.
Why does Overwatch Wellness show revision history?
The revision history makes substantive content changes visible and helps readers distinguish a new evidence review from a formatting update.
Where can I verify the research?
Use the PubMed, ClinicalTrials.gov, and FDA links in the Primary References section.
Primary References
Overwatch Wellness prioritizes primary literature, registered clinical trials, and official regulatory resources. Open the databases below to review the current evidence directly.
Article Information & Revision History
v1.0.0 — Overwatch Wellness Research Library launch
- Added standardized Research Snapshot and evidence rating.
- Expanded mechanism, timing context, comparisons, related compounds, and FAQ.
- Standardized COA presentation and added primary-reference links.
- Added Overwatch Wellness badges, visuals, sticky navigation, and branded callouts.